Celsius Holdings Drops Again as Analysts Cut Targets on UK Ban Risk
Celsius Holdings posted a second consecutive week of losses as multiple analyst price target cuts piled on top of UK regulatory risk, with 13.8% of the float sold short and valuation stretched at 20.1
Celsius Holdings Drops Again as Analysts Cut Targets on UK Ban Risk
NEW YORK, August 25 —
Celsius Holdings, Inc. (CELH) posted a second straight weekly loss as analyst price target cuts compound UK ban concerns, with 13.8% of float already short.
- Second consecutive weekly loss; shares at $35.03 with 13.8% of float sold short
- 20.1x fwd P/E on 10.6% YoY revenue growth, a growth-stock premium absorbing a regulatory scare
- Next earnings: the first hard read on whether UK regulatory noise is actually denting international revenue
Analyst Cuts Are Pricing In a Ban With No Confirmed Timeline
The UK government has moved to consult on restricting energy drink sales, but no legislation has passed. Multiple analysts have nonetheless lowered price targets, treating a regulatory proposal as a near-certain revenue impairment. That may be premature. CELH's primary revenue base is North American, and the UK's contribution to $3.0bn in TTM revenue is not disclosed as a standalone material line item. Analysts cutting on UK risk are making a bet on regulatory velocity, not current-quarter numbers.
At 20.1x Forward P/E, the Multiple Cannot Absorb Any Surprise
At $35.03 and 20.1x fwd P/E, CELH is priced for undisrupted forward growth. Revenue expanded 10.6% YoY to $3.0bn; the multiple implies investors expect that trajectory to hold. When a mature growth story faces external risk, the market does not trim estimates: it compresses the multiple. That is the mechanism behind the current wave of cuts, not a revision to CELH's North American volumes, but a lower premium assigned to the international expansion thesis that was doing the valuation work. Trailing EPS of $0.24 confirms the GAAP earnings story is thin. The bull case runs entirely through $358mn in free cash flow and the operating leverage embedded in that spread.
$358mn in Free Cash Flow Is the Bear Case's Inconvenient Fact
The bear case here is multiple compression, not business impairment. CELH generated $358mn in free cash flow on $3.0bn in TTM revenue. The gap between $0.24 in trailing EPS and that FCF figure reflects non-cash charges that distort the GAAP picture without touching the underlying cash engine. A UK ban clips international growth ambitions; it does not drain the North American machine generating that free cash. The short thesis is a valuation story. Investors tracking CELH's live FCF yield and fundamentals can find them on the CELH fundamentals page.
13.8% Short Interest Means the Next Catalyst Cuts Both Ways
With that short interest level, any positive development could force covering that amplifies a recovery: a UK regulatory delay, a credible international revenue update, or a strong earnings print. The corollary holds equally. If next quarter surfaces a sequential decline in CELH's international revenue, the short thesis gets a data anchor and covering dries up. The specific number to watch is not whether the UK passes a ban, but whether CELH's international revenue falls QoQ. That is when regulatory noise becomes fundamental impairment. Until that number surfaces, this selloff is a positioning story, not a fundamentals one.
Basis Report's full CELH analysis, including a BUY rating and valuation model, is at the CELH report; investors stress-testing that forward multiple against their own growth assumptions can model it directly in the DCF calculator.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Multiple analysts cut price targets on CELH amid UK energy drink ban concerns, driving a second consecutive week of stock losses.